Resuming clinical research activities

May 19, 2020: The Vice Dean for Clinical Research released this memo indicating initial plans for phased resumption of clinical research activities:

Guiding Principles:

  • Maintaining recommended social distancing
     
  • Masking and hand hygiene practices in the workplace
     
  • Symptom monitoring
     
  • Teleworking for staff and remote research visits for participants whenever possible
     
  • Minimizing the number of staff doing in-person activities
     
  • Minimizing the amount of time spent in the presence of others including participants

Phased Resumption of Clinical Research Activities:

  • Phase 1 - June 1
    Externally funded, Tier 2 in-person study activities that occur on Duke Health premises and can occur concomitantly with clinical care visit; continue current virtual/remote activities 
     
  • Phase 2 - June 15
    Externally funded, Tier 3 in-person study activities that occur on Duke Health premises and can occur concomitantly with clinical care visit; continue current virtual/remote activities
     
  • Phase 3 - July 15:
    Other Tier 2 and Tier 3 studies not opened in June, including community-based research

Additional details can be found in the Clinical Research Social Distancing and Infection Prevention Guidelines document and online training.